Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 20: 882-884, 1965;
8750-7587/65 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cain, S. M.
Right arrow Articles by Dunn, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cain, S. M.
Right arrow Articles by Dunn, J. E., II

Increase of arterial oxygen tension at altitude by carbonic anhydrase inhibition

Stephen M. Cain 1 and James E. Dunn II 1

1 Physiology Department, USAF School of Aerospace Medicine, Brooks Air Force Base, Texas

Unanesthetized dogs were injected intravenously with 10 mg/kg per 12 hr of the carbonic anhydrase inhibitor, acetazolamide, 24 hr before exposure to a simulated altitude of 21,000 ft (Pb = 335 mm Hg). Arterial blood samples were drawn frequently from a Teflon T cannula surgically placed in a carotid artery 1 or 2 days before the experiment. Arterial Po2, Pco2, pH, lactic, and pyruvic acid concentrations were measured. In comparison with untreated dogs, arterial Po2 at altitude was 9 mm Hg higher, on the average, in treated animals. No physiologically significant accumulation of excess lactate was found. The conclusion was made that carbonic anhydrase inhibition did offer measurable protection, with respect to arterial Po2, against altitude hypoxia and that this protection was achieved at much smaller doses of drug than had been used by other investigators.

hypoxia; altitude protection; excess lactate; lactic acid

Submitted on August 3, 1964




This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
D. E. Leaf and D. S. Goldfarb
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness
J Appl Physiol, April 1, 2007; 102(4): 1313 - 1322.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online